Edition:
United States

Foundation Medicine Inc (FMI.OQ)

FMI.OQ on NASDAQ Stock Exchange Global Select Market

35.50USD
28 Apr 2017
Change (% chg)

$1.50 (+4.41%)
Prev Close
$34.00
Open
$33.95
Day's High
$35.70
Day's Low
$33.95
Volume
51,325
Avg. Vol
65,766
52-wk High
$35.70
52-wk Low
$15.10

Latest Key Developments (Source: Significant Developments)

Foundation Medicine Q4 loss per share $1.02
Wednesday, 22 Feb 2017 04:01pm EST 

Foundation Medicine Inc : Foundation Medicine announces 2016 fourth quarter and year-end results, recent highlights and 2017 outlook . Sees FY 2017 revenue $135 million to $145 million . Q4 revenue $28.8 million versus I/B/E/S view $29.2 million . Q4 loss per share $1.02 . Q4 earnings per share view $-0.96 -- Thomson Reuters I/B/E/S . Foundation Medicine Inc says company expects to deliver between 53,000 and 56,000 clinical tests in 2017 . Company expects operating expenses will be in range of $205 million to $215 million in 2017 .FY2017 revenue view $147.8 million -- Thomson Reuters I/B/E/S.  Full Article

Foundation Medicine reports preliminary 2016 results
Monday, 9 Jan 2017 06:30am EST 

Foundation Medicine Inc : Foundation Medicine reports preliminary 2016 results .Preliminary unaudited total revenue of approximately $28.8 million in Q4 of 2016.  Full Article

Foundation Medicine Inc - FoundationOne accepted by FDA and CMS for Parallel Review and FDA Expedited Access Pathway
Tuesday, 2 Aug 2016 04:00pm EDT 

Foundation Medicine Inc : FoundationOne® accepted by FDA and CMS for parallel review and FDA expedited access pathway . FDA also accepted foundation medicine's request for review as part of its Expedited Access Pathway (EAP) for breakthrough devices .Foundation Medicine Inc says based on discussions with FDA and CMS, Foundation Medicine believes parallel review will conclude in second half of 2017.  Full Article

Foundation Medicine Inc gives FY 2016 revenue guidance
Tuesday, 23 Feb 2016 04:01pm EST 

Foundation Medicine Inc:Expects FY 2016 revenue will be in the range of $110 to $120 million.  Full Article

Foundation Medicine Inc reaffirms FY 2015 revenue guidance
Tuesday, 3 Nov 2015 04:00pm EST 

Foundation Medicine Inc:Anticipates FY 2015 revenue will be in the range of $85 to $95 million.FY 2015 revenue of $92 million - Thomson Reuters I/B/E/S.  Full Article

Foundation Medicine Inc lowers FY 2015 revenue guidance
Wednesday, 29 Jul 2015 04:00pm EDT 

Foundation Medicine Inc:Expects FY 2015 revenue will be in the range of $85 to $95 million.FY 2015 revenue of $106 mln - Thomson Reuters I/B/E/S.  Full Article

Foundation Medicine Inc and IMS Health announces collaboration to optimize targeting of precision therapies in oncology
Monday, 22 Jun 2015 09:00am EDT 

Foundation Medicine Inc:Says collaboration to advance the understanding and effectiveness of precision medicines for treating cancer.Says through collaboration, IMS Health's clients will gain unprecedented insights to rapidly assess health outcomes and effectiveness, and to improve cancer care by better connecting patients to the right targeted therapies at the right time.  Full Article

Foundation Medicine Inc gives FY 2015 revenue outlook in line with analysts' estimates
Monday, 11 May 2015 04:00pm EDT 

Foundation Medicine Inc:Expects FY 2015 revenue will be in the range of $105 - $115 million.FY 2015 revenue of $109 mln - Thomson Reuters I/B/E/S.  Full Article

More From Around the Web

BRIEF-Foundation Medicine Q4 loss per share $1.02

* Foundation Medicine announces 2016 fourth quarter and year-end results, recent highlights and 2017 outlook